Transdermal Peptide TD-1

Buy Transdermal Peptide TD-1 at Wholesale Price. Transdermal Peptide TD-1 For Sale with High Quality and Lowest Price. Inquiry Now!
Purchase Transdermal Peptide TD-1 Online From Manufacturer/Supplier, Benefits, Price - Bolise.

[ Other Name ] Transdermal Peptide TD-1; Transdermal Peptide (TD 1 (peptide))
[ Sequence ] Ala-Cys-Ser-Ser-Ser-Pro-Ser-Lys-His-Cys-Gly
[ CAS NO. ] 918629-48-8
[ Molecular Formula ] C40H66N14O16S2
[ Molecular Weight ] 1063.17
[ Appearance ] White Powder
[ Purity ] ≥98%
[ Solubility ] Soluble in water and other organic solvents.

About Transdermal Peptide TD-1
Transdermal Peptide TD-1 is a short peptide that facilitates the delivery of large molecule drugs, particularly protein-based drugs, across the skin barrier. TD-1 significantly improves the transdermal delivery efficiency of protein drugs such as insulin and human growth hormone, allowing them to reach systemic circulation. Research is being conducted on the TD-1 transdermal drug delivery system.
Transdermal Peptide TD-1 is an innovative short peptide molecule, unique in its ability to significantly promote the efficient delivery of large molecule drugs, especially protein-based drugs, across the human skin barrier. This breakthrough discovery represents a revolutionary advance in transdermal drug delivery systems, particularly in the management of diseases requiring long-term treatment and relying on protein-based drugs, such as diabetes and growth hormone deficiency.
The mechanism of action of TD-1 lies in its ability to interact with specific receptors or channels in the skin barrier, opening a "green channel" that allows large molecule drugs, such as insulin and human growth hormone, which are otherwise difficult to penetrate the skin, to pass through smoothly. This process not only improves the efficiency of transdermal drug delivery but also significantly reduces the inconvenience and patient compliance issues associated with traditional injection methods.
For insulin, the application of Transdermal Peptide TD-1 means that diabetic patients may be able to achieve painless, continuous insulin delivery through a patch-like device, thereby greatly improving their quality of life and reducing the risks of subcutaneous induration and infection caused by frequent injections. Similarly, for patients with growth hormone deficiency, the TD-1 transdermal delivery system is expected to provide a more convenient and comfortable treatment option.
As a novel transdermal peptide, Transdermal Peptide TD-1 has enormous potential in promoting the transdermal delivery of large molecule drugs, opening up new directions for the development of transdermal drug delivery systems.

[ Package ] 1g-100g in bottles.
[ Storage ] Store at -20℃ in a dry, dark place.
[ Remark ] For research purposes only. Not for human or animal use.